SAS-B deep dive: approvals climb 26% in 2025 as flower overtakes oil and pastilles surge by Adam Sheldon January 13, 2026January 14, 2026 The number of medicinal cannabis approvals through the Special Access Scheme climbed sharply in 2025, although […]
AP approvals fall as medicinal cannabis sales plateau, Penington report finds by Adam Sheldon December 3, 2025December 4, 2025
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
October SAS-B approvals hit second highest number on record by Steve Jones November 3, 2025November 4, 2025
Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025
Montu calls for single prescriber framework in TGA submission by Adam Sheldon August 28, 2025August 28, 2025
May SAS-B approvals slip from April record but still close to 20,000 by Steve Jones June 3, 2025June 3, 2025
SAS-B approvals hit all-time high in April as Tasmania spikes again by Steve Jones May 2, 2025May 2, 2025
SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
